Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 · New England Journal of Medicine · 2,010 citations
https://doi.org/10.1056/nejmoa020888
F
Filip Baert
Inagro (Belgium)(BE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
251
Papers
19.0K
Citations
54
h-index
108
i10-index
Filip Baert is an academic researcher from Inagro (Belgium). The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Eosinophilic Esophagitis. The author has an h-index of 54, co-authored 214 publications.
Papers by this author
worksDevelopment and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
2004 · Gastrointestinal Endoscopy · 1,740 citations
https://doi.org/10.1016/s0016-5107(04)01878-4
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
2017 · The Lancet · 883 citations
https://doi.org/10.1016/s0140-6736(17)32641-7
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
2022 · The Lancet · 369 citations
https://doi.org/10.1016/s0140-6736(22)00467-6
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
2023 · The Lancet · 309 citations
https://doi.org/10.1016/s0140-6736(23)00061-2
Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis
2019 · Gastroenterology · 300 citations
https://doi.org/10.1053/j.gastro.2019.08.027
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat